Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-24 @ 9:19 PM
NCT ID:
NCT03829904
Eligibility Criteria:
Inclusion Criteria:
* Patients who have been diagnosed with benign prostatic hyperplasia by a urologist
* Have been treated with conventional first-line western medicine for more than three months
* Patients with moderate to severe benign prostatic hyperplasia (IPSS score \>12 points)
* Participate voluntarily in the study
Exclusion Criteria:
* At the same time, use other Chinese herbal medicines or alternative medicine (including drugs and acupuncture) for more than one month.
* Syphilis, gonorrhea and other sexually transmitted diseases or urinary tract infections
* Urinary tract stones, prostate cancer, bladder cancer or acute and chronic renal failure
* Congenital abnormalities such as bladder neck fibrosis, interstitial cystitis or urethral stricture
* A history of genital trauma or surgery affecting the muscle or nervous system
* Patients with upper urinary tract obstruction, renal edema, etc. affecting renal function
* Unable to sign a consent form or unable to communicate with researchers
Healthy Volunteers:
False
Sex:
MALE
Study:
NCT03829904
Study Brief:
Protocol Section:
NCT03829904